Antiproliferative effects of EGFR inhibitor Cetuximab and parp inhibitor combination on non-small cell lung cancer cell line A549 and cervical cancer cell line HeLa

İdil Çetin & Mehmet Topçul · 2022-08-31

Authors
İdil Çetin, Mehmet Topçul